Milwaukee Brewers
Press Release

Brewers Statement on Pedro Severino

 

By - Apr 5th, 2022 10:00 am

MILWAUKEE – Milwaukee Brewers President of Baseball Operations David Stearns issued the following statement regarding the 80-game suspension of catcher Pedro Severino, which was announced today by Major League Baseball:

“The Milwaukee Brewers join Major League Baseball in its efforts to erase performance-enhancing drugs from our game. The organization fully supports MLB’s Joint Drug Prevention and Treatment Program. We also support Pedro during this time and will welcome him back upon the conclusion of his discipline.”

The official release from Major League Baseball can be found here.

NOTE: This press release was submitted to Urban Milwaukee and was not written by an Urban Milwaukee writer. While it is believed to be reliable, Urban Milwaukee does not guarantee its accuracy or completeness.

Mentioned in This Press Release

Organizations:

Recent Press Releases by Milwaukee Brewers

Brewers Move NLDS Watch Parties to UW Credit Union Plaza at American Family Field

Brewers Fans Can Claim Free Tickets to Celebrate the Postseason at Community Viewing Events

Athletes for Hope and Brewers Announce Partnership to Bring Champs Program to Wisconsin Schools

Partnership Integrates Brewers Alumni and Front Office Personnel into Nationally Recognized School-Based Program Focused on Mental Health, Leadership and Physical Activity

Brewers Announce Details for National League Championship Series Ticket Sales

2026 NLCS On Sale to Wisconsin Residents on Monday, October 5; On Sale to the General Public on Tuesday, October 6

Leave a Reply

You must be an Urban Milwaukee member to leave a comment. Membership, which includes a host of perks, including an ad-free website, tickets to marquee events like Summerfest, the Wisconsin State Fair and the Florentine Opera, a better photo browser and access to members-only, behind-the-scenes tours, starts at $9/month. Learn more.

Join now and cancel anytime.

If you are an existing member, sign-in to leave a comment.

Have questions? Need to report an error? Contact Us